Have a personal or library account? Click to login
Real-world clinical decision of andexanet alfa administration for intracranial hemorrhage during anticoagulant therapy using factor Xa inhibitor Cover

Real-world clinical decision of andexanet alfa administration for intracranial hemorrhage during anticoagulant therapy using factor Xa inhibitor

The Journal of Critical Care Medicine
Volume 12 (2026): Issue 1 (January 2026)
By: Shigeo Yamashiro,  Keisuke Harada,  Shunsuke Izumi,  Yusuke Morikawa,  Tomoko Ikemoto,  Koki Kameno,  Tomoaki Goto,  Yuki Ohmori,  Masatomo Kaji and  Akitake Mukasa  
Open Access
|Jan 2026

Authors

Shigeo Yamashiro

khc04160@nifty.com

Division of Neurosurgery, Department of Cerebrovascular Medicine and Surgery, Saiseikai Kumamoto Hospital, Kumamoto, Japan

Keisuke Harada

Division of Neurosurgery, Department of Cerebrovascular Medicine and Surgery, Saiseikai Kumamoto Hospital, Kumamoto, Japan

Shunsuke Izumi

Division of Neurosurgery, Department of Cerebrovascular Medicine and Surgery, Saiseikai Kumamoto Hospital, Kumamoto, Japan

Yusuke Morikawa

Division of Neurosurgery, Department of Cerebrovascular Medicine and Surgery, Saiseikai Kumamoto Hospital, Kumamoto, Japan

Tomoko Ikemoto

Division of Neurosurgery, Department of Cerebrovascular Medicine and Surgery, Saiseikai Kumamoto Hospital, Kumamoto, Japan

Koki Kameno

Division of Neurosurgery, Department of Cerebrovascular Medicine and Surgery, Saiseikai Kumamoto Hospital, Kumamoto, Japan

Tomoaki Goto

Division of Neurosurgery, Department of Cerebrovascular Medicine and Surgery, Saiseikai Kumamoto Hospital, Kumamoto, Japan

Yuki Ohmori

Division of Neurosurgery, Department of Cerebrovascular Medicine and Surgery, Saiseikai Kumamoto Hospital, Kumamoto, Japan

Masatomo Kaji

Division of Neurosurgery, Department of Cerebrovascular Medicine and Surgery, Saiseikai Kumamoto Hospital, Kumamoto, Japan

Akitake Mukasa

Department of Neurosurgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
DOI: https://doi.org/10.2478/jccm-2025-0046 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Journal RSS Feed
Language: English
Page range: 78 - 83
Submitted on: Nov 11, 2024
|
Accepted on: Oct 8, 2025
|
Published on: Jan 30, 2026
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
andexanet alfa,
factor Xa inhibitor,
intracranial hemorrhage
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other,
Anaesthesiology,
Emergency medicine and intensive-care medicine

© 2026 Shigeo Yamashiro, Keisuke Harada, Shunsuke Izumi, Yusuke Morikawa, Tomoko Ikemoto, Koki Kameno, Tomoaki Goto, Yuki Ohmori, Masatomo Kaji, Akitake Mukasa, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 12 (2026): Issue 1 (January 2026)Next article